Research-grade peptides with verified purity (≥99% by HPLC) and third-party COA documentation have well-characterized safety profiles in preclinical models. The safety of any peptide in research depends on four factors: purity and manufacturing quality, receptor selectivity, route of administration, and dose/duration.
Purity & Manufacturing Standards
Research-grade peptides should be manufactured under GMP-equivalent conditions with ≥99% purity verified by HPLC. Third-party certificates of analysis (COA) from accredited labs are the minimum standard for any research application.
Receptor Selectivity
Peptides with high receptor selectivity (e.g., Ipamorelin's selective GHSR agonism vs. GHRP-6's broad melanocortin activity) produce more predictable research profiles with fewer off-target effects.
Route of Administration
Subcutaneous injection is the most common route for research peptides and has a well-characterized safety profile in preclinical models. Oral administration is generally not viable for most peptides due to proteolytic degradation.